MarketPeel
Insider Trading Intelligence
Pricing
…
BR

Brigette Roberts

QNCX
CHIEF CORP. AFFAIRS OFFICER · QUINCE THERAPEUTICS, INC. · CIK 0001346566
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
228,855
AVG SELL PX
—
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Brigette Roberts. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
QNCX · 228,855 shares · as of May 18, 2026
01,709,3303,418,6605,127,9896,837,319SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 8 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
228,855——228,855May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
69,350——69,350May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
133,615——133,615May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,675——34,675May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
362,092——362,092May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,070,107——2,070,107May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,837,319——6,837,319May 18, 2026Jun 11, 2026 ↗
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
124,830——124,830May 18, 2026Jun 11, 2026 ↗
Other insiders · QNCX
Loading peer insiders…
About this filer
CIK 0001346566
ROLE
Chief Corp. Affairs Officer
PRIMARY
QNCX
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0001346566DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback